LifeVantage CorporationLFVNNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +31.26% | +21.13% | +12.64% | +0.73% | -27.79% |
| Gross Profit Growth | +34.54% | +24.31% | +13.21% | +0.25% | -33.64% |
| EBITDA Growth | +0.00% | +71.65% | -22.01% | -14.52% | -70.74% |
| Operating Income Growth | +0.00% | +109.57% | -26.19% | -11.75% | -85.79% |
| Net Income Growth | +0.00% | +109.16% | +50.11% | +18.02% | -89.18% |
| EPS Growth | +0.00% | +115.38% | +45.45% | +13.33% | -89.62% |
| EPS Diluted Growth | +0.00% | +100.00% | +50.00% | +21.43% | -88.58% |
| Weighted Average Shares Growth | -3.18% | -0.60% | +0.13% | +1.94% | +3.54% |
| Weighted Average Shares Diluted Growth | +4.48% | +2.42% | +1.73% | +0.95% | -3.28% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | -59.95% | +0.00% | -69.66% |
| Free Cash Flow Growth | +0.00% | +0.00% | -63.76% | +0.00% | -80.40% |
| Receivables Growth | +50.02% | -16.35% | -36.02% | +160.21% | +29.27% |
| Inventory Growth | +12.97% | +15.20% | +16.02% | +21.76% | +12.20% |
| Asset Growth | -1.95% | +11.78% | +13.65% | +0.19% | -0.47% |
| Book Value per Share Growth | +4.76% | +12.32% | +14.85% | +17.43% | +15.03% |
| Debt Growth | -3.02% | -5.60% | -6.19% | -16.25% | -20.00% |
| R&D Expense Growth | -100.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -55.49% | -52.78% | +33.23% | +0.03% | -14.97% |